15 July 2018 (Sunday)

(1300-1800h) CVCT Asia Workshop

The CVCT Asia Workshop brings together a highly selected, by invitation only, top faculty involved in the science of cardiovascular clinical trials, with a unique mix of backgrounds: academia, research organizations, and industry R&D. The ethos of the meeting is to allow ample time for discussion. Speakers/discussants serve mainly to prompt lively panel discussion. The emphasis is on interaction among experts with as little lecturing as possible.

Chairpersons/ Facilitators: Vlado Perkovic (Australia), Carolyn Lam, (Singapore), Faiez Zannad (France), Bertram Pitt (USA), Yee Leong Teoh (Singapore)

TOPICS TO BE DISCUSSED (Invited speakers subject to confirmation):

Clinical trials in Asia Pacific: Where are we & what does the future hold?

Speaker: Vlado Perkovic, George Institute (Australia)


Yee Leong Teoh, Singapore Clinical Research Institute

Say Beng Tan, SingHealth (Singapore)

Changing landscape of healthcare in Asia: What are payer priorities?

Speaker: Jeremy Lim, Oliver Wyman


Robert White, Medtronic

Patrick Tan (Singapore)

Device trials: What makes industry choose Asia & how can we improve?

Speaker: Ken Stein, Boston Scientific


Robert White, Medtronic

David Kaye (Australia)

Drug trials: What makes industry choose Asia & how can we improve?

Speaker: Lothar Roessig, Bayer


XingLi Wang, Novartis;

Ru San Tan (Singapore)

Registry & big data approaches in CV trials: Are we there yet?

Speaker: Mikhail Kosiborod (USA)


Terrance Chua (Singapore)

Peter Fenici (USA)

Digital technology in clinical trials: Where are we?

Speaker: Frank Kramer, Bayer

Discussants: Faiez Zannad (France)

Ken Stein, Boston Scientific



Subject to final faculty acceptance

Brooke Allocco (Boston Scientific)
Giuseppe Caracciolo (Menarini Fondazione)
Alessandro Casini (Menarini Fondazione)
Josep Comin-Colet (Spain)
Mark Chan (Singapore)
Chi Keong Ching (Singapore)
Myeong-Chan Cho (Korea)
Wolfram Döhner (Germany)
Frank Eisenhaber (Singapore)
Peter Fenici (Astra Zeneca)
Junbo Ge (China)
Barry Greenberg (US)
Martin Huelsmann (UK)
David Kaye (Australia)
Florence Keime-Guibert (Servier)
Koichiro Kinugawa (Japan)
Joerg Koglin (Merck)
Mikhail Kosiborod (US)
Frank Kramer (Bayer)
Carolyn Lam (Singapore)
Jeremy Lim (Singapore)
Toon-Wei Lim (Singapore)
Iain Macdougall (UK)
Athanasios Manolis (Greece)
Claudio Mori (Vifor)
Daisaku Nakatani (Japan)
Christopher Nessel (Janssen)
Torbjorn Omland (Norway)
Vlado Perkovic (Australia)
Bertram Pitt (US)
Dorairaj Prabhakaran (India)
Arthur Mark Richards (Singapore)
Lothar Roessig (Bayer)
Yves Rosenberg (US)
Yasuhiko Sakata (Japan)
Afshin Salsali (Boehringer Ingelheim)
Kaori Shinagawa (Japan)
Cheerag Shirodaria (Covance)
David Sim (Singapore)
Stuart Spencer (UK)
Kenneth Stein (Boston Scientific)
Tavintharan Subramaniam (Singapore)
Say Beng Tan (Singapore)
Ru San Tan (Singapore)
Patrick Tan (Singapore)
Yee Leong Teoh (Singapore)
Dirk van Veldhuisen (Netherlands)
Adriaan Voors (Netherlands)
Xingli Wang (Novartis Pharmaceuticals Corporation)
Scott Wasserman (Amgen)
Robert White (Medtronic)
Raymond Wong (Singapore)
Lijing Yan (China)
Terrance Chua (Singapore)
Faiez Zannad (France)